Starpharma Holdings Limited (AU:SPL) has released an update.
Starpharma Holdings Limited has announced a partnership with Medicxi, leading to the creation of Petalion Therapeutics Limited, which will be introduced in an investor webinar hosted by CEO Cheryl Maley. The webinar, scheduled for 9 April 2024, will allow investors to submit questions and learn more about the strategic partnership and the new company’s prospects. A separate webinar in early May will provide an update on Starpharma’s business operations.
For further insights into AU:SPL stock, check out TipRanks’ Stock Analysis page.
